News Headlines Article

‘Sunshine Act’ Gets Guarded Reaction
Health Leaders Media

The federal government’s long-delayed rollout this month of the “Sunshine Act” mandate to disclose financial relationships between drug and device manufacturers and healthcare providers is getting a mostly guarded reception from key groups that will be affected by it. For the most part, when it came to commenting on the 287-page final rule, those lobbying groups and professional associations avoided trash talking the final rule.